References
- Alonso A, Martínez JL. Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 1997 May; 41(5):1140–1142. https://doi.org/10.1128/AAC.41.5.1140
- Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012 May;19(5):455–477. https://doi.org/10.1089/cmb.2012.0021
- Bavaro DF, Fiordelisi D, Angarano G, Monno L, Saracino A. Targeted therapies for autoimmune/idiopathic nonmalignant diseases: Risk and management of opportunistic infections. Expert Opin Drug Saf. 2020 Jul;19(7):817–842. https://doi.org/10.1080/14740338.2020.1767585
- Berg G, Erlacher A, Smalla K, Krause R. Vegetable microbiomes: Is there a connection among opportunistic infections, human health and our ‘gut feeling’? Microb Biotechnol. 2014 Nov;7(6):487–495. https://doi.org/10.1111/1751-7915.12159
- Bostanghadiri N, Ghalavand Z, Fallah F, Yadegar A, Ardebili A, Tarashi S, Pournajaf A, Mardaneh J, Shams S, Hashemi A. Characterization of phenotypic and genotypic diversity of Stenotrophomonas maltophilia strains isolated from selected hospitals in Iran. Front Microbiol. 2019 May 29;10:1191. https://doi.org/10.3389/fmicb.2019.01191
- Brooke JS, Di Bonaventura G, Berg G, Martinez JL. Editorial: A multidisciplinary look at Stenotrophomonas maltophilia: An emerging multi-drug-resistant global opportunistic pathogen. Front Microbiol. 2017 Aug;8:1511. https://doi.org/10.3389/fmicb.2017.01511
- Chang YT, Lin CY, Chen YH, Hsueh PR. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. 2015 Sep;6:893. https://doi.org/10.3389/fmicb.2015.00893
- Han L, Zhang RM, Jia L, Bai SC, Liu XW, Wei R, Cui CY, Sun RY, Wang MG, Cai DT, et al. Diversity of L1/L2 genes and molecular epidemiology of high-level carbapenem resistance Stenotrophomonas maltophilia isolates from animal production environment in China. Infect Genet Evol. 2020 Dec;86:104531. https://doi.org/10.1016/j.meegid.2020.104531
- Kardan-Yamchi J, Hajihasani A, Talebi M, Khodaparast S, Azimi A, Rahbar M, Fallah F, Douraghi M. Intra-hospital dissemination of clinical and environmental isolates of Stenotrophomonas maltophilia from Tehran. Lett Appl Microbiol. 2021 Mar;72(3):325–331. https://doi.org/10.1111/lam.13416
- Kim YJ, Park JH, Seo KH. Presence of Stenotrophomonas maltophilia exhibiting high genetic similarity to clinical isolates in final effluents of pig farm wastewater treatment plants. Int J Hyg Environ Health. 2018 Mar;221(2):300–307. https://doi.org/10.1016/j.ijheh.2017.12.002
- Kullar R, Wenzler E, Alexander J, Goldstein EJC. Overcoming Stenotrophomonas maltophilia resistance for a more rational therapeutic approach. Open Forum Infect Dis. 2022 Mar;9(5):ofac095. https://doi.org/10.1093/ofid/ofac095
- Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X. Molecular Evolutionary Genetics Analysis across computing platforms. Mol Biol Evol. 2018 Jun 1;35(6):1547–1549. https://doi.org/10.1093/molbev/msy096
- Li D, Wong CH, Seet MF, Kuan N. Isolation, characterization, and inactivation of Stenotrophomonas maltophilia from leafy green vegetables and urban agriculture systems. Front Microbiol. 2019 Nov; 10:2718. https://doi.org/10.3389/fmicb.2019.02718
- Maraolo AE, Licciardi F, Gentile I, Saracino A, Belati A, Bavaro DF. Stenotrophomonas maltophilia infections: A systematic review and meta-analysis of comparative efficacy of available treatments, with critical assessment of novel therapeutic options. Antibiotics. 2023 May;12(5):910. https://doi.org/10.3390/antibiotics12050910
- Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MT, Fookes M, Falush D, Keane JA, Parkhill J. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015 Nov;31(22): 3691–3693. https://doi.org/10.1093/bioinformatics/btv421
- Paopradit P, Srinitiwarawong K, Ingviya N, Singkhamanan K, Vuddhakul V. Distribution and characterization of Stenotrophomonas maltophilia isolates from environmental and clinical samples in Thailand. J Hosp Infect. 2017 Oct;97(2):185–191. https://doi.org/10.1016/j.jhin.2017.06.006
- Rello J, Kalwaje Eshwara V, Lagunes L, Alves J, Wunderink RG, Conway-Morris A, Rojas JN, Alp E, Zhang Z. A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis. Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):319–323. https://doi.org/10.1007/s10096-018-3428-y
- Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America Guidance on the treatment of AmpC β-lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections. Clin Infect Dis. 2022 Jul 6;74(12):2089–2114. https://doi.org/10.1093/cid/ciab1013